Tietueen sitaatit

APA-viite (7. p.)
Yasunori Murata, M., Shigeru Tanzawa, M., Toshihiro Misumi, P., Hiroshige Yoshioka, M., Eisaku Miyauchi, M., Kiichiro Ninomiya, M., . . . Nobuhiko Seki, M. (2023). Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study. Elsevier.
Chicago-viite (17. p.)
Yasunori Murata, MD, et al. Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study. Elsevier, 2023.
MLA-viite (9. p.)
Yasunori Murata, MD, et al. Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study. Elsevier, 2023.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.